Project Grant 2315798
- The National Science Foundation (NSF), under its Biological Sciences program (CFDA 47.074), awarded a $1,059,027 Project Grant to the Regents of the University of California, Riverside (UC Riverside), a public research university. This collaborative research project aims to investigate the evolution of the megadiverse plant bugs, the insect family Miridae, which are both significant crop pests and beneficial predators. The research team will construct a phylogeny of plant bugs using...
- This $849,713 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to elucidate RNA-RNA interaction networks during interbacterial interactions involving the bacterium Pseudomonas aeruginosa. The research team at Boston Children's Hospital seeks to define the small RNA (sRNA) interaction network in P. aeruginosa and decode the regulatory roles played by sRNAs during its interactions with other bacteria. The project will...
- The National Science Foundation awarded a $381,493 Project Grant to the Regents of the University of California at Riverside under the Biological Sciences federal grant program (CFDA 47.074) to support a Research Experiences for Undergraduates Site focused on next-generation cell biology of plants and plant pathogens. The three-year award, which runs from March 2021 through February 2024, will fund research experiences and training for undergraduate students in major problems related to plant...
- This $299,999 National Science Foundation project grant under the Biological Sciences program (CFDA 47.074) will support research exploring the RNA world and RNA-peptide world hypotheses using a novel dynamic combinatorial chemistry system at the University of Houston, a minority-serving institution. The two-year project beginning August 1, 2022 aims to advance understanding of the role of RNA and peptides in the origins of life. Investigators will employ a system using benzonuclease to cleave...
- This $299,779 National Science Foundation project grant under the Biological Sciences program (CFDA 47.074) funds research at Louisiana State University from August 2022 to July 2024 to design an RNA-based dual regulator for repetitive gene expression regulation. The research integrates biological experiments and computational studies to train scientists and engineers in interdisciplinary research. It also aims to cultivate a multidisciplinary perspective for problem-solving. Specifically, the...
- The National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) awarded a $810,001 project grant to The Trustees of the University of Pennsylvania to study the role of N6-methyladenosine (m6A) modifications in regulating plant gene expression and response to bacterial pathogens. The 4-year project aims to characterize the addition and removal of m6A on plant RNAs and investigate how these epitranscriptomic processes impact a plant's ability to recognize and respond to...
- This National Science Foundation (NSF) Biological Sciences (CFDA 47.074) Project Grant award provides $270,000 to fund a Postdoctoral Research Fellowship in Biology for FY 2025 through May 31, 2028. The project aims to uncover how epigenetic modifications influence bacterial adaptation, particularly in response to antimicrobial compounds. The research will investigate the role of epigenetic modifications in bacterial adaptation to environmental changes, the underlying mechanisms, and possible...
- This $300,122 National Science Foundation project grant supports research titled "Collaborative Research: EDGE FGT: Functional Genomic Tools for Parasitic Nematodes and Their Bacterial Symbionts." Awarded on August 15, 2021 to the University of California, Riverside for the period through July 31, 2025, the grant funds basic biological research under the NSF's Biological Sciences program (CFDA 47.074). Specifically, the University of California, Riverside will develop new functional...
- The National Science Foundation awarded a $138,000 Project Grant to support research activities from November 1, 2021 to October 31, 2023 under the Biological Sciences program (CFDA 47.074). The grant funding will enable the grantee to conduct research at the University of Pittsburgh aimed at furthering understanding of the evolution of gene regulatory networks through empirical and theoretical approaches. The Biological Sciences program seeks to advance the field and strengthen the national...
- The Regents of the University of California at Riverside received a $1.56M Project Grant award from the National Science Foundation Division of Integrative Organismal Systems. The award is part of the NSF's Biological Sciences program (CFDA 47.074) and will fund research from September 2021 through August 2025 to decipher the robustness mechanisms of the stem promoting transcription factor gradient. The Biological Sciences program aims to advance the field and strengthen the national...
The National Science Foundation (NSF) awarded a $919,999 Project Grant under the Biological Sciences program (CFDA 47.074) to the Regents of the University of California at Riverside. This 3-year grant, beginning September 1, 2023, supports research to investigate the evolution and functional role of small regulatory RNAs (sRNAs) in diverse bacterial lineages, particularly those living symbiotically within pest insect hosts. The project aims to determine how sRNA sequence divergence and binding specificity affect their regulatory functions and gene targets across divergent bacteria. Additionally, the researchers will examine the conservation of mRNA targets among sRNAs encoded at distant genomic locations. By unraveling the mechanisms of sRNA evolution, this work will enhance understanding of bacterial gene regulation, adaptation, and interactions with host organisms. The broader impacts include training undergraduate students, engaging the public through outreach activities, and promoting inclusivity in STEM education.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $920.0k | 7/10/23 |